These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 33113546)
1. Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab. Islam Y; Andersen L; Agarwal-Sinha S Ophthalmic Res; 2022; 65(2):229-236. PubMed ID: 33113546 [TBL] [Abstract][Full Text] [Related]
2. Fluorescein angiographic features post-intravitreal bevacizumab for retinopathy of prematurity: can they support rescue laser photocoagulation to the avascular retina. Gonzalez A; Agarwal-Sinha S Can J Ophthalmol; 2020 Oct; 55(5):373-381. PubMed ID: 32835673 [TBL] [Abstract][Full Text] [Related]
3. Fluorescein Angiography in Retinopathy of Prematurity: Comparison of Infants Treated with Bevacizumab to Those with Spontaneous Regression. Mansukhani SA; Hutchinson AK; Neustein R; Schertzer J; Allen JC; Hubbard GB Ophthalmol Retina; 2019 May; 3(5):436-443. PubMed ID: 31044736 [TBL] [Abstract][Full Text] [Related]
4. Chronic Vascular Arrest as a Predictor of Bevacizumab Treatment Failure in Retinopathy of Prematurity. Toy BC; Schachar IH; Tan GS; Moshfeghi DM Ophthalmology; 2016 Oct; 123(10):2166-75. PubMed ID: 27506484 [TBL] [Abstract][Full Text] [Related]
5. Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression. Vural A; Ekinci DY; Onur IU; Hergünsel GO; Yiğit FU Int Ophthalmol; 2019 Oct; 39(10):2267-2274. PubMed ID: 30604251 [TBL] [Abstract][Full Text] [Related]
6. Computed Analysis of Retinal Vascular Growth After Bevacizumab Treatment of Retinopathy of Prematurity Until Age 3 Years. Hammer JD; Nguyen H; Palmer J; Furtney S; Agarwal-Sinha S Clin Ther; 2023 Jan; 45(1):4-16. PubMed ID: 36581528 [TBL] [Abstract][Full Text] [Related]
7. Involution patterns of retinopathy of prematurity after treatment with intravitreal bevacizumab: implications for follow-up. Isaac M; Tehrani N; Mireskandari K; Eye (Lond); 2016 Mar; 30(3):333-41. PubMed ID: 26869159 [TBL] [Abstract][Full Text] [Related]
8. Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity. Tahija SG; Hersetyati R; Lam GC; Kusaka S; McMenamin PG Br J Ophthalmol; 2014 Apr; 98(4):507-12. PubMed ID: 24403566 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings. Lepore D; Quinn GE; Molle F; Baldascino A; Orazi L; Sammartino M; Purcaro V; Giannantonio C; Papacci P; Romagnoli C Ophthalmology; 2014 Nov; 121(11):2212-9. PubMed ID: 25001158 [TBL] [Abstract][Full Text] [Related]
10. RETINAL VASCULAR DEVELOPMENT WITH 0.312 MG INTRAVITREAL BEVACIZUMAB TO TREAT SEVERE POSTERIOR RETINOPATHY OF PREMATURITY: A Longitudinal Fluorescein Angiographic Study. Lorenz B; Stieger K; Jäger M; Mais C; Stieger S; Andrassi-Darida M Retina; 2017 Jan; 37(1):97-111. PubMed ID: 27454223 [TBL] [Abstract][Full Text] [Related]
11. A Spectrum of Regression Following Intravitreal Bevacizumab in Retinopathy of Prematurity. Chen TA; Shields RA; Bodnar ZH; Callaway NF; Schachar IH; Moshfeghi DM Am J Ophthalmol; 2019 Feb; 198():63-69. PubMed ID: 30312578 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal injection of bevacizumab for retinopathy of prematurity. Kuniyoshi K; Sugioka K; Sakuramoto H; Kusaka S; Wada N; Shimomura Y Jpn J Ophthalmol; 2014 May; 58(3):237-43. PubMed ID: 24566819 [TBL] [Abstract][Full Text] [Related]
13. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis. Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024 [TBL] [Abstract][Full Text] [Related]